inContAlert vs NeuroPace

inContAlert logo

inContAlert

Know your body. Own your life

13 employees · est. 2017 · Bayreuth, Germany

VS
NeuroPace logo

NeuroPace

The NeuroPace RNS System is the only brain-responsive neurostimulation system for refractory focal epilepsy. Rx Only

237 employees · est. 1999 · Mountain View, United States

NeuroPace is the older company (2017 vs 1999); NeuroPace is the larger of the two.

Side-by-Side Comparison

inContAlert NeuroPace
Founded
2017 1999 older
Headquarters
Bayreuth, Germany Mountain View, United States
Employees
13 237 larger
Industry
AI, Digital Health, Health Care Health Care, Manufacturing, Medical Devices
Funding Stage
Seed Grant
Total Funding
$3.55M $307.30M
Funding Rounds
8 9
Services
Bladder fullness monitoring, Sensor data analysis, Machine learning recommendations, App-based notifications RNS System Installation, Epilepsy Monitoring, Clinical Support, Patient and Provider Education, Data Analysis for Seizure Patterns
Target Customers
Incontinence Patients, Healthcare Providers, Nursing and Care Facilities, Family Members of Patients Patients with Drug-Resistant Epilepsy, Healthcare Providers, Neurologists, Epileptologists, Clinical Researchers, Neurosurgeons
Taxonomy
MedTechIncontinenceWearable TechnologyBladder DysfunctionMHealthDeep Tech +6 Brain-responsive NeurostimulationRefractory Focal EpilepsyImplantable DevicesNeurological DisordersEpilepsy TreatmentResponsive Neurostimulation +8
Website
incontalert.de neuropace.com
inContAlert logo

About inContAlert

inContAlert, founded in 2017 and headquartered in Germany, is a MedTech startup that operates at the intersection of AI, Digital Health, and Medical Devices. The company's slogan, "Know your body. Own your life.", encapsulates its mission to assist individuals with bladder dysfunction in leading a n...

NeuroPace logo

About NeuroPace

NeuroPace, headquartered in the United States, has been pioneering solutions in the health care and medical devices industry since its founding in 1999. The company's flagship product, the RNS System, is the first and only brain-responsive neurostimulation device targeting refractory focal epilepsy,...

Also comparing in this category

Comparing more than these two?

Get inContAlert, NeuroPace and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does inContAlert compare?

A PDF of inContAlert and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

inContAlert was founded in 2017, based in Bayreuth, Germany, with 13 employees. inContAlert, founded in 2017 and headquartered in Germany, is a MedTech startup that operates at the intersection of AI, Digital Health, and Medical Devices. The company's slogan, "Know your body. Own. NeuroPace was founded in 1999, based in Mountain View, United States, with 237 employees. NeuroPace, headquartered in the United States, has been pioneering solutions in the health care and medical devices industry since its founding in 1999. The company's flagship product, the RNS System,.
inContAlert has raised $3.55M and NeuroPace $307.30M. Latest stage: inContAlert Seed, NeuroPace Grant.
Both work in Health Care and Medical Devices.

Compare inContAlert with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at inContAlert on 28 May 2026, and NeuroPace on 2 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes